In silico robustness testing of a compendial HPLC purity method by using of a multidimensional design space build by chromatography modeling-Case study pramipexole.
Purity testing of the active pharmaceutical ingredient (API) pramipexole is performed using an official (compendial) and harmonized method published in the European Pharmacopeia (E.P.) and United States Pharmacopeia (USP). According to this monograph the successful chromatographic separation of the API from impurities is achieved on a C18 column with gradient elution of an ion pairing buffer of pH 3.0 (mobile phase A) and acetonitrile (mobile phase B). Although not recommended in general, compendial methods are often adapted for purity testing of generic formulations. In this paper a novel approach to evaluate method robustness of an adapted method - prior of full method validation - is described. Based on Quality-by-Design (QbD) principles, a small number of experiments are performed, which after entering them into a chromatography modeling software allow to visualize a multidimensional "Design Space", a region, in which changes in method parameters will not significantly affect the results as defined in the ICH guideline Q8(R2) leading to a more flexible method handling in routine analysis. For two different recommended C18 columns a multidimensional Design Space (Method Operating Design Region, MODR) was constructed to study the robustness of the adapted method with a newly developed Robustness Module. In a full factorial design the following six parameters were varied at three levels (low, nominal, high): gradient time, temperature, pH of the aqueous eluent (A), flow rate, start- and end concentration of the organic mobile phase component (eluent B). The resulting 3(6)=729 experiments were performed in silico from the previously constructed models for Design Space in less than 1min and showed that the required resolution of 2.0 could not be reached in all experiments for the two columns which were recommended by the E.P. (failure rate 25% and 16%, respectively). However, by adjusting the gradient time, we were able to fulfill the requirements with a failure rate of zero. For the aqueous eluent a separate "Eluent Design Space" study was performed, which allows the construction of ionic strength vs. ion pairing concentration models to identify the optimum combination of the concentrations for the buffer and the ion-pairing reagent.
Steiner & Co., Deutsche Arzneimittel GmbH & Co. KG, Wallenroder Strasse 12-14, 13435 Berlin, Germany; Freie Universität Berlin, Institute of Pharmacy, Königin-Luise-Strasse 2+4, 14195 Berlin, Germany. Electronic address: alexander.schmidt@steinerarznei-berlin.de.
Alexander H
AH
Schmidt
Steiner & Co., Deutsche Arzneimittel GmbH & Co. KG, Wallenroder Strasse 12-14, 13435 Berlin, Germany.
Mijo
M
Stanic
Molnár-Institute, Schneeglöckchenstrasse 47, 10407 Berlin, Germany.
Imre
I
Molnár
D000097:Acetonitriles / Q000737:chemistry; D052160:Benzothiazoles / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical / Q000379:methods; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D003198:Computer Simulation; D004340:Drug Contamination; D006863:Hydrogen-Ion Concentration; D008962:Models, Theoretical; D000077487:Pramipexole; D013696:Temperature
D000097:Acetonitriles; D052160:Benzothiazoles; D000077487:Pramipexole; C032159:acetonitrile
Design Space; HPLC method development; Pramipexole; Quality by Design; Robustness in routine quality control